AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06292715 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: microwave ablation of the spleen
Description: Ultrasound-guided percutaneous puncture for splenic ablation treatment
Study NCT06292715 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Splenic artery balloon implantation
Description: Splenic artery balloon implantation
Study NCT05572619 — intervention group
Intervention type: DEVICE
Intervention: 1st Reading
Description: The medical team visually checks the non-contrast CT without cELVO and diagnose the large vessel occlusion.
Study NCT05572619 — intervention group
Intervention type: DEVICE
Intervention: 2nd Reading
Description: The medical team visually checks the non-contrast CT with assistance from the cELVO and diagnose the large vessel occlusion.
Study NCT05798624 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound between 6+0 and 6+7 weeks of pregnancy
Description: Location of implantation of the GS (gestational sac) amended to Naji et al, defined as 3 possible implantation sites (A: fundal, B: anterior, C: posterior)~Size of gestational sac
Study NCT06473272 — intervention group
Intervention type: OTHER
Intervention: Cardiovascular and cerebrovascular diseases
Description: Cardiovascular and cerebrovascular diseases
Study NCT05250492 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prosthetic hip surgery
Description: Total hip prosthesis performed by an anterior approach with intra-articular infiltration of an anesthetic product intraoperatively.~OR~- Total hip prosthesis performed by an anterior approach with infiltration of the same anesthetic product by ultrasound-guided PENG block intraoperatively.
Study NCT05250492 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Prosthetic hip surgery
Description: Total hip prosthesis performed by an anterior approach with intra-articular infiltration of an anesthetic product intraoperatively.~OR~- Total hip prosthesis performed by an anterior approach with infiltration of the same anesthetic product by ultrasound-guided PENG block intraoperatively.
Study NCT04817319 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oral care with/without aerosolization
Description: These treatments involve instruments that produce aerosolization: ultrasonic scaler, rotary instrumentation for caries care, dental extraction, tooth polishing.~These care correspond to examinations of the oral cavity, intraoral X-rays or even periodontal pocket probing.
Study NCT00280839 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topiramate
Study NCT00280839 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT06263933 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Semi-directional interviews
Description: In the end of the intervention. In the end of DIPEM Or in the end of control group.~This intervention will be held after one month of hospitalization.
Study NCT06263933 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Semi-directional interviews
Description: In the end of the intervention. In the end of DIPEM Or in the end of control group.~This intervention will be held after one month of hospitalization.
Study NCT06263933 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: routine care
Description: routine care
Study NCT06263933 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: session of mutual assistance with a mediator psychologist
Description: session of mutual assistance with a mediator psychologist
Study NCT05405504 — intervention group
Intervention type: DEVICE
Intervention: Remote Dielectric Sensing (ReDS)
Description: Non-invasive device designed for the measurement of lung fluid using extremely low power electromagnetic waves. The ReDS Pro System V2.7 system has CE approval (3900874CE01) and FDA clearance.
Study NCT04952961 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training in Vulval Self-Examination
Description: Face-to-face training in vulval self-examination Supplemented with use of aids ( hand mirror, mobile phone with selfie-stick), patient information leaflet, reminders to self-examine
Study NCT06150248 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Education Intervention
Description: This intervention is based on the Social Cognitive Theory (SCT) and The Health Belief Model (HBM) to improve knowledge and promote lifestyle adherence in terms of healthy diet behaviour and physical activity among the undergraduate students. This program will include educational booklets and educational classes include six weeks of in-person education sessions and six weeks of social media messaging. The course will include six weekly teaching units (lectures and group discussions, 45-60 minutes each):~Topic 1: To understand the causes and prevention strategies for overweight and obesity.~Topic 2: To understand food based approaches to reduce or prevent overweight and obesity.~Topic 3: To understand the importance of regular physical activity. Topic 4: To demonstrate how snacking can be a healthy habit. Topic 5: To learn how to read and interpret food labels. Topic 6: To understand how to prepare healthy meals.
Study NCT06150248 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No intervention
Description: They will have their regular curriculums and normal physical activity routine.
Study NCT04564092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DaTSCAN™ Ioflupane (123I) Injection
Description: Each participant will receive a single administration of DaTSCAN™ ioflupane (123I) injection by bolus IV injection with a nominal iodine (123I) activity of 111 MBq ±10%, in a maximum volume of 5 mL.
Study NCT04981418 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: customised pelvic support shorts
Description: These apply targeted compressive forces to the pelvic girdle through selective precisely positioned reinforced lycra panels that aim to stabilize and align body segments to improve function and reduce unwanted movements. The construction material (Nylon and Elastane) is durable and breathable, and its mechanical properties enable it to provide dynamic stability and support (rather than the rigid support provided by off-the-shelf belts) during movement/functional activities. This aims to optimise comfort and movement to increase wear compliance, which is crucial as any benefits gained rely upon this.
Study NCT04981418 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Women will be provided with up to a maximum of 4 exercises from a pre-defined list of exercises. Suggested dosages are referred to in the protocol. The exercise programme contains a range of exercise focused around the pelvic girdle and hips (including movement control and strengthening
Study NCT04981418 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Women will be provided with up to a maximum of 4 exercises from a pre-defined list of exercises. Suggested dosages are referred to in the protocol. The exercise programme contains a range of exercise focused around the pelvic girdle and hips (including movement control and strengthening
Study NCT04981418 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: advice
Description: standardised advice on management of pelvic girdle pain, through a discussion centred around 'Guidance for Mothers-to-be and New Mothers: Pregnancy-related Pelvic Girdle Pain' booklet (https://pogp.csp.org.uk/system/files/pogp-pgppat_3.pdf). This publicly available, specialist physiotherapy approved, standardised leaflet, provides information reflective of current best practice. The participant can use this as an ongoing resource.
Study NCT04981418 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: advice
Description: standardised advice on management of pelvic girdle pain, through a discussion centred around 'Guidance for Mothers-to-be and New Mothers: Pregnancy-related Pelvic Girdle Pain' booklet (https://pogp.csp.org.uk/system/files/pogp-pgppat_3.pdf). This publicly available, specialist physiotherapy approved, standardised leaflet, provides information reflective of current best practice. The participant can use this as an ongoing resource.
Study NCT04858932 — intervention group
Intervention type: DEVICE
Intervention: Continuous Glucose Monitor
Description: a handheld reader and a wearable sensor placed on the back of the arm used to obtain glucose measurements
Study NCT04858932 — intervention group
Intervention type: DEVICE
Intervention: Wrist Actigraphy Device
Description: a watch like wearable sensor
Study NCT04858932 — intervention group
Intervention type: DEVICE
Intervention: Food Weight Scale
Description: a scale to measure food weight
Study NCT04858932 — intervention group
Intervention type: DEVICE
Intervention: Smart Body Weight Scale
Description: a full body composition scale that provides fat and muscle mass, water retention, bone mass, and weight trends
Study NCT04807010 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Prostate Artery Embolization
Description: Prostate artery embolization reduces symptoms from benign prostatic hyperplasia by delivering embolic materials to the prostate through the prostatic arteries.
Study NCT04807010 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Prostate Artery Embolization
Description: Prostate artery embolization reduces symptoms from benign prostatic hyperplasia by delivering embolic materials to the prostate through the prostatic arteries.
Study NCT04807010 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Prostate Artery Embolization
Description: Angiogram without embolization initially. At 6 months patients will be allowed to crossover to prostate artery embolization.
Study NCT05819970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allium Sativum Oil
Description: Allium sativum oil will be used as non-vital pulpotomy medicament
Study NCT05819970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Turmeric Gel
Description: Turmeric gel will be used as non-vital pulpotomy medicament
Study NCT04904185 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cyclophosphamide
Description: Cyclophosphamide 500 mg/m2 is administered i.v. on day -4, -3 and -2
Study NCT04904185 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Fludarabine Phosphate
Description: Fludarabine Phosphate 30 mg/m2 is administered on day -4 and -3
Study NCT05158673 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of Cocoa flavonoids
Description: Dietary supplement: The administration of two capsules of 500 mg orally of placebo (excipient q.s. starch capsule) 1 every 12 hours, for 12 weeks
Study NCT04904185 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Multiple Antigen Specific Endogenously derived T cells
Description: Antigen specific, ex vivo expanded T cells derived from peripheral blood T cells
Study NCT04904185 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Pembrolizumab
Description: Pembrolizumab 2 mg/kg is administered on day -1 and on day 21. The medicine is administered over 30 minutes
Study NCT05158673 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Cocoa flavonoids
Description: Dietary supplement: Two 500 mg capsules of the flavonoid supplement (whose total flavonoid content is 15 mg/capsule) orally every 12 hours (one in the morning and one at night) for 12 weeks
Study NCT06072547 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Access to all varieties of on! 4mg nicotine pouches (Berry, Citrus, Cinnamon, Wintergreen, Mint, Coffee, and Original)
Description: Access to all varieties of on! 4mg nicotine pouch products (Berry, Citrus, Cinnamon, Wintergreen, Mint, Coffee, and Original), throughout the trial.
Study NCT05486819 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol Injection
Description: adding lignocaine or sodium bicarbonate to propofol to reduce pain during injection
Study NCT06021873 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SADI-S
Description: Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy
Study NCT05375942 — intervention group
Intervention type: DRUG
Intervention: Inflectra
Description: 1. To describe the characteristics of patients newly initiated on Inflectra.
Study NCT05375942 — intervention group
Intervention type: DRUG
Intervention: Inflectra
Description: 2. To describe 6-month outcomes after initiating Inflectra, among patients who have 6 months follow-up information in the CorEvitas' RA Registry.
Study NCT06072547 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Access to Original on! 4mg nicotine pouches
Description: Access to non-flavored (i.e., Original) 4mg on! nicotine pouch products throughout the trial.
Study NCT06072547 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-Flavored then complete flavor on! nicotine pouches
Description: Access to non-flavored (i.e., Original) on! 4mg nicotine pouch products during the first 3 weeks and then access to all varieties (Berry, Citrus, Cinnamon, Wintergreen, Mint, Coffee, and Original) of on! 4mg nicotine pouch products during the rest of the trial
Study NCT04796259 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Malt ingredient
Description: Solution with malt-derived ingredient
Study NCT04796259 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Non-alcoholic beer solids
Description: Solution with non-alcoholic beer solids
Study NCT04853953 — intervention group
Intervention type: OTHER
Intervention: Incidence of bleeding complications in ARDS patients on veno-venous ECMO
Description: All bleeding complications (especially cerebral bleedings) will be analyzed in the study groups. At the bleeding event, laboratory parameters of coagulation will be collected and the intensity of the ECMO treatment
Study NCT05486819 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Propofol Injection
Description: adding lignocaine or sodium bicarbonate to propofol to reduce pain during injection
Study NCT06723964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AP505
Description: AP505 is a Anti-PD-L1 and Anti-VEGF Antibody Fusion Protein.
Study NCT06277804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LTC004 in Combination With Cyclophosphamide and Fludarabine
Description: LTC004 was given on day 1 and cyclophosphamide (250 mg/m2) in combination with fludarabine (25 mg/m2) was given on days 3 and 4 of each cycle, Q3W, until disease progression, withdrawn informed or intolerable
Study NCT04982666 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole-Food, Plant-Based Diet
Description: This diet is focused on nutritional needs with natural, minimally-processed plant foods.
Study NCT04982666 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: FODMAP Diet
Description: An elimination diet of fermentable, oligosaccharides, disaccharides, monosaccharides and polyols
Study NCT06557889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab + Cisplatin/Carboplatin + 5-FU
Description: * 4 cycles of combination treatment: 4 cycles of pembrolizumab (200 mg IV on Day 1 of each 3-week cycle) in combination with chemotherapy with platinum salts (cisplatin (100 mg/m2 IV on Day 1 of each 3-week cycle) or carboplatin (AUC 5 IV on Day 1 of each 3-week cycle), at the investigator's choice) and 5-FU (1000 mg/m2/day IV continuous from Day 1-4 of each 3-week cycle).~* Maintenance phase: pembrolizumab is continued as monotherapy for up to 24 months of treatment in total (from the first injection of cycle 1).
Study NCT06270199 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Standard treatment
Study NCT06270199 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogenic fetal mesenchymal stem cells from umbilical cord - three infusions
Description: 3 doses of 5 million MSC will be administered
Study NCT06270199 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogenic fetal mesenchymal stem cells from umbilical cord - six infusions
Description: 6 doses of 5 million MSC will be administered
Study NCT06172777 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: suspected asthma
Description: enrollment 200 asthma patients
Study NCT06172777 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: suspected COPD
Description: enrollment 200 COPD patients
Study NCT06172777 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: confirmed asthma
Description: enrollment 200 patients
Study NCT06172777 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: confirmed COPD
Description: enrollment 200 patients
Study NCT05583331 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cataract surgery
Description: Cataract surgery will be performed as per local practice and standard guidelines.
Study NCT05583331 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cataract surgery
Description: Cataract surgery will be performed as per local practice and standard guidelines.
Study NCT05583331 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Vitrectomy
Description: Vitrectomy will be performed as per local practice and standard guidelines.
Study NCT05583331 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vitrectomy
Description: Vitrectomy will be performed as per local practice and standard guidelines.
Study NCT05945979 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: A power supplement with biotin
Description: A power dietary supplement containing aminoacids and vitamins
Study NCT06724939 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: self-adhesive bulk-fill resin composite
Description: surefil one self-adhesive bulk-fill composite
Study NCT06724939 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: self-adhesive bulk-fill resin composite
Description: surefil one self-adhesive bulk-fill composite
Study NCT06452888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clinical decision support system.
Description: The clinical decision support system includes evidence-based clinical pathway, standard operating procedures (SOP) of performance indicators, a quality coordinator, and monitoring and feedback system of performance measures. Patients in the intervention group will receive the organizational management based on the guidelines and conduct intervention management for patients with actue ischemic stroke. The clinical decision system will classify the patients into risk factors, automatically generate treatment measures according to the guidelines, in order to standardize the treatment of physicians. Such as the management of complications after stroke, the treatment of antiplatelet, anticoagulation, antihypertensive and hypoglycemic.
Study NCT06452888 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: no intervention
Description: No intervention indicated that the physicians among control hospital provide routine
Study NCT06585436 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: partial caries removal
Description: removal of all cavity caries except last layer related to the pulp
Study NCT05028569 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOTOX
Description: Intramuscular Injection
Study NCT05028569 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: BOTOX
Description: Intramuscular Injection
Study NCT05028569 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intramuscular Injection
Study NCT05650281 — intervention group
Intervention type: OTHER
Intervention: NO INTERVENTION
Description: NO INTERVENTION
Study NCT05978947 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZyMōt Multi 850µL device
Description: The ZyMōt Multi 850µL device is a laboratory tool designed for use in assisted reproductive technology (ART) procedures such as intrauterine insemination (IUI) and in vitro fertilization (IVF). It is a sperm preparation device that uses a proprietary patented technology to isolate and select motile sperm from semen samples for use in ART procedures.
Study NCT05254483 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: UNICEF kid power program immediately
Description: The intervention will be delivered via the UNICEF Kid Power website (https://www.unicefkidpower.org/) and any screened device such as a computer, smartphone, smart TV or an electronic tablet can be used to watch the videos and perform the assigned physical activity.~Participants will self-select activities 5 days a week. The participants will have the choice to undertake the physical activity in bouts and accumulate it over the course of the day.~To promote adherence to intervention, a weekly email with reminder to perform the physical activity will be sent to parents. In addition, research-based articles on the importance of physical activity and behavior change in children will also be emailed.
Study NCT05254483 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: UNICEF kid power program for waitlist control
Description: The wait-list control group will perform physical activity as usual and will only receive a weekly email on the importance of healthy dietary habits in children. The intervention will last 12 weeks. At the end of the study, the wait-list control group will be offered the UNICEF Kid Power intervention for a duration of 12-weeks
Study NCT05254483 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ActiGraph Accelerometer
Description: The participants will be mailed accelerometers and instructed to wear for 7 consecutive days during their waking hours, prior to the start of intervention. The mail containing the accelerometer will accompany pictorial instructions, explaining in detail the correct way of wearing it.
Study NCT05122364 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Telerehabilitation and telecoaching
Description: Language Sessions online and coaching parents online to improve language and social outcomes of their children